Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DLAT | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | SLC25A5 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | ZSCAN5A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | OAZ3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | GAGE13 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | RP11-1212A22.4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | TOR3A | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | FGF6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | MAGEB16 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | DENND3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |